{
  "parties": [
    "SightLife Surgical, Inc., a Delaware corporation, having its principal place of business at 1200 6th Ave, Ste. 300, Seattle, WA 98101 (\"Surgical\")",
    "Imprimis Pharmaceuticals"
  ],
  "effective_date": null,
  "governing_law": "Delaware",
  "payment_terms": null,
  "termination_clause": {
    "text": "Termination.     2.1. This Agreement shall be effective on the later of the dates that it is executed by Imprimis and Surgical (the \"Effective Date\") and shall terminate pursuant to the terms of the SOW (the \"Term\").         2.2. Surgical shall immediately cease to provide any further Services under this Agreement and/or any applicable SOW upon receipt of notice from Imprimis that Imprimis is terminating this Agreement and/or such SOW. Upon termination of this Agreement and/or such SOW, Surgical shall be entitled to payment for Services completed prior to such termination. Thereafter, Imprimis shall owe Surgical no further amounts or obligations in law or equity.     Page 1 of 11\n\n\n\n\n\n        3. Sales Commissions. In consideration of the Services provided hereunder, Imprimis shall pay Surgical sales",
    "start": 2238,
    "end": 3049,
    "confidence": 0.72,
    "source": "regex"
  },
  "_doc_id": "SightLife Surgical, Inc. - STRATEGIC SALES _ MARKETING AGREEMENT.txt",
  "_char_count": 23895,
  "_provenance": {
    "governing_law": {
      "source": "spacy"
    }
  }
}